DSIP vs Insulin
Overview
DSIP is primarily a sleep & recovery peptide, while Insulin is used for weight management & metabolic.
This page compares DSIP and Insulin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| DSIP | Insulin | |
|---|---|---|
| Category | Sleep & Recovery | Weight Management & Metabolic |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 100-300 mcg | Highly individualized; type 1 diabetes basal-bolus regimens typically require 0.5–1.0 units/kg/day total; type 2 diabetes is often initiated with basal insulin at 10 units or 0.1–0.2 units/kg/day, titrated to individual glycemic targets |
| Frequency | before bed | Once daily (long-acting basal analogs) to four or more times daily (basal-bolus or continuous subcutaneous insulin infusion); prandial doses given 0–15 minutes before meals for rapid-acting analogs or 30 minutes before meals for regular human insulin |
| Reported benefits | Improved deep sleep, stress reduction, recovery enhancement, pain reduction | Glycemic control, prevention of diabetic ketoacidosis, reduction of microvascular complications (retinopathy, nephropathy, neuropathy), life-sustaining therapy in type 1 diabetes, HbA1c reduction in type 2 diabetes |
| Reported side effects | Very well-tolerated, possible grogginess | Hypoglycemia, weight gain, injection-site lipohypertrophy, rare hypersensitivity reactions, peripheral edema at initiation |
Key differences
Primary use. DSIP is categorised under Sleep & Recovery, while Insulin falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. DSIP: not FDA-approved; compounding permitted with a prescription as of April 2026. Insulin: FDA-approved.
Dosing. DSIP is typically dosed at 100-300 mcg (before bed). Insulin is typically dosed at Highly individualized; type 1 diabetes basal-bolus regimens typically require 0.5–1.0 units/kg/day total; type 2 diabetes is often initiated with basal insulin at 10 units or 0.1–0.2 units/kg/day, titrated to individual glycemic targets (Once daily (long-acting basal analogs) to four or more times daily (basal-bolus or continuous subcutaneous insulin infusion); prandial doses given 0–15 minutes before meals for rapid-acting analogs or 30 minutes before meals for regular human insulin).
Can you stack them?
Some protocols combine peptides, but stacking DSIP and Insulin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between DSIP and Insulin?
- DSIP is primarily a sleep & recovery peptide, while Insulin is used for weight management & metabolic. DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Insulin is FDA-approved for one or more indications.
- What is DSIP used for?
- Delta sleep-inducing peptide.
- What is Insulin used for?
- The foundational peptide hormone for glycemic management in type 1 and type 2 diabetes mellitus.
- Can you take DSIP and Insulin together?
- Some users combine peptides within a single protocol, but stacking DSIP and Insulin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is DSIP or Insulin FDA-approved?
- DSIP is not FDA-approved; compounding permitted with a prescription (as of April 2026). Insulin is FDA-approved for one or more indications.